MENU
OGN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Organon & Co (OGN) Ownership - Who owns Organon & Co?
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more
Profile
Industry
N/A
Address
30 Hudson Street
Phone
+1 551 430-6900
Employees
10000
Web
https://www.organon.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
4.73B
P/E Ratio
4.64
Total Cash
693M
Projected Growth
N/A
Total Debt
8.76B
Revenue
6.26B
Risk (Beta)
N/A
Dividend Yield
0.06
Total Cash/Share
2.71
Total Debt/Equity
N/A
Revenue/Share
24.44 USD as % of share price
Fundamentals
OGN
Capitalization
4.73B
P/E Ratio
4.64
Risk (Beta)
N/A
Dividend Yield
0.06
Total Cash
693M
Total Cash/Share
2.71
Total Debt
8.76B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
24.44%
Revenue
6.26B
ROE
N/A
Book Value
-70M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
4.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3M
Current Ratio
1.54
Current Revenue Per Employee
159800.00
Dividends Per Share - Security
0.28
EBITDA
1.44B
Float
N/A
Float - Current
N/A
Gross Income Margin
57.26
Revenue To Assets
8.89
Shares Held By Institutions
4.56B
Shares Outstanding - Current
256M
Total Liabilities
12.1B
Total Volume MTD
N/A
Value
1
Gain YTD
1.636
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
N/A
Address
30 Hudson Street
Phone
+1 551 430-6900
Employees
10000
Web
https://www.organon.com